Gratifyingly, anti-TNF-α mAb administration to new onset T1D/T2D NOD mice served to enduringly restore euglycemia, self-tolerance, and normal insulin signaling. This evidence concerns the gene INS and dentatorubral-pallidoluysian atrophy.